全文获取类型
收费全文 | 188577篇 |
免费 | 14467篇 |
国内免费 | 6932篇 |
专业分类
耳鼻咽喉 | 1308篇 |
儿科学 | 2954篇 |
妇产科学 | 2582篇 |
基础医学 | 32902篇 |
口腔科学 | 3418篇 |
临床医学 | 13895篇 |
内科学 | 28964篇 |
皮肤病学 | 2996篇 |
神经病学 | 13740篇 |
特种医学 | 4016篇 |
外国民族医学 | 304篇 |
外科学 | 11601篇 |
综合类 | 28791篇 |
现状与发展 | 36篇 |
预防医学 | 11170篇 |
眼科学 | 1907篇 |
药学 | 26535篇 |
20篇 | |
中国医学 | 7386篇 |
肿瘤学 | 15451篇 |
出版年
2024年 | 123篇 |
2023年 | 2208篇 |
2022年 | 3225篇 |
2021年 | 5791篇 |
2020年 | 5144篇 |
2019年 | 5170篇 |
2018年 | 5295篇 |
2017年 | 5565篇 |
2016年 | 5742篇 |
2015年 | 6637篇 |
2014年 | 13620篇 |
2013年 | 14401篇 |
2012年 | 12214篇 |
2011年 | 13484篇 |
2010年 | 12522篇 |
2009年 | 12128篇 |
2008年 | 10330篇 |
2007年 | 9027篇 |
2006年 | 8232篇 |
2005年 | 7472篇 |
2004年 | 6487篇 |
2003年 | 5585篇 |
2002年 | 4402篇 |
2001年 | 3770篇 |
2000年 | 3354篇 |
1999年 | 2735篇 |
1998年 | 2417篇 |
1997年 | 2234篇 |
1996年 | 1926篇 |
1995年 | 2016篇 |
1994年 | 1901篇 |
1993年 | 1539篇 |
1992年 | 1409篇 |
1991年 | 1248篇 |
1990年 | 1091篇 |
1989年 | 926篇 |
1988年 | 820篇 |
1987年 | 750篇 |
1986年 | 732篇 |
1985年 | 1078篇 |
1984年 | 1039篇 |
1983年 | 627篇 |
1982年 | 759篇 |
1981年 | 618篇 |
1980年 | 537篇 |
1979年 | 385篇 |
1978年 | 302篇 |
1977年 | 254篇 |
1976年 | 247篇 |
1975年 | 168篇 |
排序方式: 共有10000条查询结果,搜索用时 46 毫秒
101.
102.
背景与目的:肾透明细胞癌(clear cell renal cell carcinoma,ccRCC)是最常见的肾癌类型,它与代谢密切相关。探讨沉默信息调节因子4(silent information regulator 4,SIRT4)过表达或谷氨酰胺(glutamine,Gln)剥夺对ccRCC细胞增殖、凋亡的影响。方法:慢病毒构建SIRT4和突变体H161Y过表达的Caki-2细胞株,利用无Gln的培养基来构建Gln剥夺模型,并通过体外增殖活力实验[细胞计数试剂盒-8(cell counting kit-8,CCK-8)]和克隆形成实验来分析两者对Caki-2细胞增殖和生长能力的影响;利用DCFH-DA荧光探针检测细胞内活性氧自由基(reactive oxygen species,ROS)水平进而评估Gln代谢对细胞ROS含量的影响;进一步通过线粒体膜电位检测、凋亡检测和蛋白质印迹法(Western blot)检测凋亡相关分子,分析SIRT4过表达以及Gln剥夺对Caki-2细胞凋亡的影响。结果:过表达SIRT4可抑制Gln代谢从而抑制Caki-2细胞增殖,另外还原性物质还原型烟酰胺腺嘌呤二核苷酸磷酸(reduced nicotinamide adenine dinucleotide phostate,NADPH)的生成减少能够增加细胞内ROS含量,促进细胞凋亡。而Gln剥夺抑制细胞增殖和促进细胞凋亡的效果均比过表达SIRT4明显,但长期缺乏Gln将导致细胞无法生长。结论:无论是过表达SIRT4还是Gln剥夺均能抑制ccRCC细胞增殖,促进凋亡。 相似文献
103.
Joshua Demb Esther K. Wei Monika Izano Stephen Kritchevsky Helen Swede Anne B. Newman Michael Shlipak Tomi Akinyemiju Steven Gregorich Dejana Braithwaite 《Journal of Geriatric Oncology》2019,10(2):265-271
Objectives
We examined the association between three inflammatory markers (Interleukin (IL)-6, C-reactive protein (CRP), tumor necrosis factor (TNF)-α) and incident lung cancer using baseline, updated, and averaged inflammatory measures in older adults.Methods
We fitted multivariable Cox models to assess whether circulating levels of inflammation markers were associated with incident lung cancers in the Health Aging, Body and Composition (HealthABC) prospective cohort of 3075 older adults aged 70–79?years at baseline. IL-6 and CRP were measured biennially, whereas TNF-α was measured at baseline.Results
Baseline levels of IL-6 were significantly associated with incident lung cancer risk in a model that adjusted for age, gender, race, and site (Model 1) (Hazard RatioT3 vs. T1: 3.34, 95% Confidence Interval: 1.91, 5.85) and in a model adjusted for health factors linked to chronic inflammation (Model 2) (HR T3 vs. T1: 2.57, 95% CI: 1.41, 4.65). The associations observed in time-updated IL-6 (HR T3 vs. T1: 2.47, 95% CI: 1.43, 4.28), cumulatively averaged IL-6 (HR T3 vs. T1: 2.47, 95% CI: 1.43, 4.35), and baseline CRP levels (HR T3 vs. T1: 1.85, 95% CI: 1.11, 3.08) with incident lung cancer in Model 1 were not statistically significant in Model 2.Conclusions
Baseline CRP and IL-6 levels were associated with increased risk of lung cancer in Model 1 and both models, respectively. Chronic IL-6 inflammation, as quantified by repeated measures was associated with incident lung cancer in Model 1, but not Model 2. Further research is needed to understand the role of CRP and IL-6 in lung carcinogenesis. 相似文献104.
目的 探讨微小RNA-148a-3p(miR-148a-3p)对丝裂原活化蛋白激酶激酶激酶9(MAP3K9)的靶向调控作用及对胃癌细胞增殖和凋亡的影响。方法 向对数生长期胃癌细胞株MGC-803转染miR-148a-3p模拟物(mimics组)和阴性对照(NC组),以未转染的MGC-803细胞为对照组;采用实时定量PCR(QPCR)检测各组miR-148a-3p水平以评价转染效率,MTT法检测各组细胞增殖能力,流式细胞术检测各组细胞凋亡情况,分别采用QPCR和Western blotting检测Bcl-2、Bax、caspase-3及MAP3K9 mRNA和蛋白水平,同时采用双荧光素酶报告实验验证miR-148a-3p与MAP3K9的靶向作用关系。结果 QPCR结果显示,对照组、NC组和mimics组的miR-148a-3p水平分别为1.021±0.123、1.087±0.196和2.854±0.368,与对照组和NC组比较,mimics组的miR-148a-3p水平升高(P<0.05)。mimics组MGC-803细胞的增殖活力较其余两组减弱(P<0.05)。mimics组MGC-803细胞凋亡率为(15.2±1.6)%,高于对照组的(3.5±0.9%)%和NC组的(4.5±1.1)%,差异具有统计学意义(P<0.05)。与对照组和NC组比较,mimics组的MAP3K9和Bcl-2的mRNA和蛋白水平均下调,而Bax和caspase-3的mRNA和蛋白水平均上调(P<0.05);双荧光素酶报告实验证实MAP3K9是miR-148a-3p的直接作用靶点。结论 MiR-148a-3p可抑制胃癌细胞MGC-803的增殖并诱导其凋亡,可能通过靶向MAP3K9来发挥抑癌作用,调控miR-148a-3p/MAP3K9轴在胃癌防治中有一定应用前景。 相似文献
105.
目的探讨单纯 Ilizarov 环形外固定技术治疗合并骨筋膜室综合征的胫骨平台骨折的疗效。方法2013 年 9 月—2017 年 3 月,收治 30 例合并骨筋膜室综合征的胫骨平台骨折患者,采用单纯 Ilizarov 环形外固定技术治疗。男 23 例,女 7 例;年龄 23~43 岁,平均 34.4 岁。致伤原因:交通事故伤 12 例,高处坠落伤 4 例,摔伤 8 例,重物砸伤 6 例。受伤至入院时间 1~12 h,平均 4.8 h。骨折 Schatzker 分型:Ⅱ型 1 例、Ⅲ型 3 例、Ⅳ型 10 例、Ⅴ型 7 例、Ⅵ型 9 例。30 例均因骨筋膜室综合征行切开减压;切开减压至手术时间为 10~15 d,平均 12.5 d。治疗后采用膝关节学会评分系统(KSS)及 Ilizarov 方法研究与应用协会(ASAMI)协议评价膝关节功能。结果手术时间 110~155 min,平均 123.1 min;术中出血量 100~500 mL,平均 245 mL;术后住院时间 3~5 d,平均 3.8 d。患者均获随访,随访时间 20~24 周,平均 22.7 周。除 2 例患者出现针道感染征象外,无其他并发症发生。X 线片复查显示骨折均愈合,愈合时间 10~20 周,平均 14.6 周。末次随访时,膝关节 KSS 临床评分总分为 70~95 分,平均 87.5 分;功能评分总分为 70~90 分,平均 79.0 分。参照 ASAMI 协议评价获优 24 例、良 3 例、可 2 例、差 1 例。结论对于合并骨筋膜室综合征的胫骨平台骨折,单纯 Ilizarov 环形外固定技术治疗后患者关节功能可以基本恢复且并发症少,是一项相对安全、有效的治疗方法。 相似文献
106.
Tomoya Kurokawa Takuya Nakagawa Keisuke Matsusaka Masaki Fukuyo Masato Mima Kiyoshi Misawa Bahityar Rahmutulla Jun‐ichiro Ikeda Toyoyuki Hanazawa Yoshitaka Okamoto Atsushi Kaneda 《Cancer science》2020,111(4):1407-1416
Irradiation, or chemoradiotherapy, is a curative treatment for oropharyngeal squamous cell carcinoma (OPSCC). Its invasiveness, however, can often negate its efficacy. Therefore, developing methods to predict which patients would benefit from irradiation is urgent. Promoter DNA hypermethylation was recently reported to correlate with favorable OPSCC prognosis. It is still unclear, however, whether there is an association between promoter DNA methylation and response to irradiation. In this study, we analyzed DNA methylation in the specimens from 40 OPSCC patients who had undergone irradiation, using the Infinium assay. Our results showed significant correlation between high levels of promoter DNA methylation and better response to treatment (P < 0.01). We used the 10 most differentially‐methylated genes between responders and non–responders to develop a panel of predictive markers for efficacy. Our panel had high sensitivity, specificity and accuracy (92%, 93% and 93%, respectively). We conducted pyrosequencing to quantitatively validate the methylation levels of 8 of the 10 marker genes (ROBO1, ULK4P3, MYOD1, LBX1, CACNA1A, IRX4, DPYSL3 and ELAVL2) obtained by Infinium. The validation by pyrosequencing showed that these 8 genes had a high prediction performance for the training set of 40 specimens and for a validation set of 35 OPSCC specimens, showing 96% sensitivity, 89% specificity and 94% accuracy. Methylation of these markers correlated significantly with better progression‐free and overall survival rates, regardless of human papillomavirus status. These results indicate that increased DNA methylation is associated with better responses to irradiation therapy and that DNA methylation can help establish efficacy prediction markers in OPSCC. 相似文献
107.
108.
《Vaccine》2019,37(24):3234-3240
Leucine aminopeptidase (FhLAP) and cathepsin L1 (FhCL1) of Fasciola hepatica play a critical role in parasite feeding, migration through host tissue, and immune evasion. These antigens have been tested for immune protection as single components with variable degrees of success. The chimeric-protein approach could improve protection levels against fasciolosis. Previously, we reported the design and construction of a chimeric protein composed of antigenic sequences of FhLAP and FhCL1 of F. hepatica. The goal of the present study was to express and evaluate the immune-protective capacity of this chimeric protein (rFhLAP-CL1) in sheep. Animals were randomly allocated into five groups with five animals in each group. Groups 1, 2 and 3 were immunized twice with 100 μg, 200 μg and 400 μg of rFhLAP-CL1 emulsified with Quil A adjuvant, whereas groups 4 and 5 were the adjuvant control and infection control groups, respectively. The animals were then challenged with 200 metacercariae two weeks after the rFhLAP-CL1 booster. The fluke burden was reduced by 25.5%, 30.7% (p < 0.05) and 46.5% (p < 0.01) in sheep immunized with 100 μg, 200 μg and 400 μg of chimeric protein, respectively, in comparison to the infection control group. There was a reduction of 22.7% (p < 0.05) and 24.4% (p < 0.01) in fecal egg count in groups 2 and 3, respectively, compared to the infection control group. Sheep immunized with chimeric protein produced F. hepatica excretion-secretion product-specific total IgG antibody, which were increased after challenge. Moreover, the levels of rFhLAP-CL1-specific IgG1 and IgG2 isotypes in immunized sheep increased rapidly two weeks after the first immunization and were significantly more elevated than those of the control groups, indicating a mixed Th1/Th2 response. This is a preliminary evaluation of the chimeric protein rFhLAP-CL1 as a possible immunogen against F. hepatica infection in sheep. 相似文献
109.
嗜肺军团菌是一种可以引起军团菌肺炎和庞蒂亚克热的兼性胞内病原菌,主要侵染阿米巴原虫和人类巨噬细胞。该菌在宿主胞内能依靠Dot/Icm IVB型分泌系统产生的效应蛋白成功逃避溶酶体的降解。本文主要对嗜肺军团菌的致病物质、胞内存活与增殖机制及其效应蛋白的生物学功能进行综述,详细介绍嗜肺军团菌的毒力因子与致病机制,为军团病防治的研究提供新思路,也为其他胞内病原菌所致感染性疾病的研究提供重要的借鉴意义。 相似文献
110.
目的:探讨FOLFOX4化疗方案联合全身免疫治疗在中晚期肝细胞癌中的应用价值及疗效。方法:回顾性分析2例在空军军医大学唐都医院就诊的中晚期肝癌患者资料,给予FOLFOX4全身化疗联合胸腺法新的免疫治疗后患者病情缓解,疾病完全控制。分析FOLFOX4化疗方案在中晚期肝癌中的应用价值,及联合应用时机选择。结果:2例中晚期患者中,其中1例患者合并有双肺转移瘤,全身化疗后7个周期肺转移瘤消失,肿瘤标志物降至正常。另1例患者肝癌破裂根治术后,患者腹腔转移瘤切除术后,给予全身联合治疗,患者2年内病情稳定,肿瘤标志物正常。结论:FOLFOX4化疗方案在中晚期肝癌患者中的效果是肯定的,联合胸腺法新的全身辅助免疫治疗有助于增强全身化疗的疗效,改善患者的总体生存预后。 相似文献